DBV Technologies is the pioneer of an exciting non-invasive epicutaneous delivery system that offers unique advantages for a wide range of diagnostic and medical treatments. Based on its proprietary
VIASKIN® technology, DBV Technologies is currently focused on the development of epicutaneous delivery systems for
allergy diagnostics,
allergy desensitisation therapy,
vaccine administration and
cosmaceuticals.